EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Oxycodone/naloxone versus placebo for acute spinal pain in compliant participants: secondary analysis of a randomised clinical trial

Zhiwei Yang, Caitlin Mp Jones, Laurent Billot, Anthony Devaux, Sana Shan, Richard O Day, Melanie Hamilton, Bart Koes, Jane Latimer, Christopher G Maher, Andrew J McLachlan, Hanan McLachlan und 2 weitere

British Journal of Anaesthesia · 2026-02 · 136 (2) · 618-626

DOI: 10.1016/j.bja.2025.10.019 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Anaesthesia, 2026-02. Verfasst von Zhiwei Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Musculoskeletal Health, Sydney Local Health District, Sydney, NSW, Australia; Sydney School of Public Health, Faculty of Medicine and H…. Hauptthemen laut MEDLINE: Oxycodone, Naloxone, Analgesics, Opioid, Acute Pain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Faculty of Medicine and Health, University of Sydney, University of Sydney, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: A recent randomised controlled trial found that an oxycodone/naloxone combination was not effective at relieving acute back/neck pain compared with placebo. However, only half of the participants were compliant with the regimen. Therefore, the current study estimated treatment efficacy in participants who complied with the regimen. METHODS: A complier average causal effect analysis was prespecified in the original trial's statistical analysis plan. It was performed using (i) a propensity-weighting approach, (ii) a joint modelling approach, and (iii) a propensity-matching approach, with compliance defined using different cut-off points (taking ≥20%, ≥40%, ≥60%, and ≥80% of the prescribed dose). The primary outcome was pain severity at week 6. Key secondary outcomes were pain severity at weeks 2, 4, 12, 26, and 52. A per-protocol analysis was also conducted at all time points. RESULTS: After propensity-weighting, a small but significant difference favouring the placebo group for pain severity was found at week 6 (mean difference, 0.78; 95% confidence interval, 0.22-1.33; P=0.006). Analysis using different approaches, pain outcomes at other time points, and sensitivity analysis using different cut-offs of compliance either favoured the placebo group or showed no difference between groups. CONCLUSIONS: This secondary analysis of a randomised controlled trial highlights the non-effectiveness of an oxycodone/naloxone combination in acute spinal pain compared with placebo, even when the population complies with the treatment regimen. These results, and the original study results, argue against the use of oxycodone/naloxone combinations for acute spinal pain. CLINICAL TRIAL REGISTRATION: OPAL (ACTRN12615000775516).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxycodoneNaloxoneAnalgesics, OpioidAcute PainBack PainHumansFemaleMaleMiddle AgedAdultDouble-Blind MethodDrug CombinationsTreatment OutcomePain MeasurementAged

Stichwörter der Autor:innen

acute back painacute neck paincompliancenaloxoneopioidsplacebo

Substanzen

OxycodoneNaloxoneAnalgesics, OpioidDrug Combinationsoxycodone naloxone combination

Autor:innen und Institutionen

  • Institute for Musculoskeletal Health, Sydney Local Health District, Sydney, NSW, Australia; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. Electronic ad…
  • Institute for Musculoskeletal Health, Sydney Local Health District, Sydney, NSW, Australia; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
  • St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
  • Department of General Practice, Erasmus MC, Rotterdam, The Netherlands; Research Unit of General Practice, Department of Public Health & Centre for Muscle and Joint Health, University of Southern Denmark, Odense, Denmar…
  • Sydney Pharmacy School, The University of Sydney, Sydney, NSW, Australia.

Förderung

  • Faculty of Medicine and Health, University of Sydney
  • University of Sydney
  • National Health and Medical Research Council

Zitieren

APA

Yang, Z., Mp Jones, C., Billot, L., Devaux, A., Shan, S., Day, R. O., Hamilton, M., Koes, B., Latimer, J., Maher, C. G., McLachlan, A. J., McLachlan, H., Webb, M., & Lin, C. C. (2026). Oxycodone/naloxone versus placebo for acute spinal pain in compliant participants: secondary analysis of a randomised clinical trial. British Journal of Anaesthesia, 136(2), 618-626. https://doi.org/10.1016/j.bja.2025.10.019

Vancouver

Yang Z, Mp Jones C, Billot L, Devaux A, Shan S, Day RO, et al. Oxycodone/naloxone versus placebo for acute spinal pain in compliant participants: secondary analysis of a randomised clinical trial. British Journal of Anaesthesia. 2026;136(2):618-626. doi:10.1016/j.bja.2025.10.019

BibTeX
@article{Yang2026,
  author = {Yang, Zhiwei and Mp Jones, Caitlin and Billot, Laurent and Devaux, Anthony and Shan, Sana and Day, Richard O and Hamilton, Melanie and Koes, Bart and Latimer, Jane and Maher, Christopher G and McLachlan, Andrew J and McLachlan, Hanan and Webb, Melissa and Lin, Chung-Wei Christine},
  title = {Oxycodone/naloxone versus placebo for acute spinal pain in compliant participants: secondary analysis of a randomised clinical trial},
  journal = {British Journal of Anaesthesia},
  year = {2026},
  volume = {136},
  number = {2},
  pages = {618--626},
  doi = {10.1016/j.bja.2025.10.019}
}
Kostenlos starten →